Pharmena S.A.

PHR

PLPHRMN00011

Personal Products

Delayed Warsaw S.E. Other stock markets 07:16:01 18/06/2024 pm IST			5-day change	1st Jan Change
5.96 ^PLN	-0.67%		-1.97%	-16.06%

24/05	Pharmena S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
29/02	Pharmena S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Pharmena S.A. announced that it expects to receive PLN 0.299998 million in funding

August 29, 2018

Pharmena S.A. (WSE:PHR) announced a private placement of 2,600,000 shares at PLN 0.115384 per share for gross proceeds of PLN 300,000 on August 29, 2018. The transaction is subject approval of shareholders which will held on September 26, 2018.

Latest news about Pharmena S.A.

Pharmena S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	24/05	CI
Pharmena S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	29/02	CI
Pharmena S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023	27/11	CI
Pharmena S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	28/23/28	CI
Grupo AC MARCA SL entered into an agreement to acquire Dermena from Pharmena S.A.	18/23/18	CI
Pharmena S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/23/26	CI
Pharmena S.A. Reports Earnings Results for the Nine Months Ended September 30, 2022	25/22/25	CI
Pharmena S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	26/22/26	CI
Pharmena S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	27/22/27	CI
Pharmena S.A. Reports Earnings Results for the Nine Months Ended September 30, 2021	26/21/26	CI
Pharmena S.A. Reports Earnings Results for the Half Year Ended June 30, 2021	27/21/27	CI
Pharmena S.A. Reports Earnings Results for the Full Year Ended December 31, 2020	12/21/12	CI
Pharmena S.A. announced that it has received PLN 15.0858 million in funding from Pelion S.A.	30/20/30	CI
Pharmena S.A. announced that it expects to receive funding from Pelion S.A.	09/20/09	CI
Pharmena S.A. announced that it expects to receive PLN 0.299998 million in funding	29/18/29	CI
Cortria Corporation announced that it has received $0.2 million in funding from Pharmena S.A.	29/18/29	CI
Cortria Corporation announced that it has received $0.3 million in funding from Pharmena S.A.	30/17/30	CI
Cortria Corporation announced that it has received $0.25 million in funding from Pharmena S.A.	25/17/25	CI
Korporacja Inwestycyjna Polskiej Farmacji Sp. z o.o. sold 6.91% stake in Pharmena Spolka Akcyjna.	28/16/28	CI
Pelion S.A. acquired an additional 6.91% stake in Pharmena Spolka Akcyjna.	27/16/27	CI
Cortria Corporation announced that it has received $0.25 million in funding from Pharmena S.A.	24/16/24	CI
Pharmena SA Announces Earnings Results for the First Quarter of 2016	13/16/13	CI
Pelion S.A. acquired an additional 4.09% stake in Pharmena Spolka Akcyjna.	28/15/28	CI
Korporacja Inwestycyjna Polskiej Farmacji Sp. z o.o. acquired additional 3.98% stake in Pharmena Spolka Akcyjna.	03/13/03	CI

Chart Pharmena S.A.

Duration

Period

More charts

Company Profile

Pharmena SA is a Poland-based producer of cosmetics and pharmaceuticals. The Companyâs products range encompasses Dermena, a line of products against hair loss; Dermena Plus, a shampoo reducing the symptoms of dandruff and preventing excessive hair loss; Accos, an anti-acne gel; Allerco, a line of hypo-allergic emollients for body care, Thermi, a gel after thermal burn and sunburn; and Revium, a line of anti-wrinkle treatment products. Pharmena SA maintains multidirectional research works and application studies in conjunction with a number of research centers in Europe, the United States and Canada. As of December 31, 2011, the Company had one wholly owned subsidiary, Cortria Corporation, based in the United States. As of December 31, 2011, Polska Grupa Farmaceutyczna SA held a 43.65% stake in the capital. The main shareholder of the Company is Pelion SA.

Sector

Personal Products

More about the company

Income Statement Evolution

More financial data

Sector Cosmetics & Perfumes

	1st Jan change	Capi.
PHARMENA S.A.	-16.06%	16.45M
L'ORÉAL	-2.69%	256B
KAO CORPORATION	+16.69%	19.9B
GALDERMA GROUP AG	0.00%	19.54B
SHISEIDO COMPANY, LIMITED	+15.59%	12.67B
COTY INC.	-21.14%	8.47B
AMOREPACIFIC CORPORATION	+27.59%	8.21B
PROYA COSMETICS CO.,LTD.	+6.53%	5.76B
KOSÉ CORPORATION	+4.49%	4.02B
NATURA &CO HOLDING S.A.	-12.85%	3.71B